USPTO serial 79118858
BOIRON
Reviewed by CopyMark Law Group
Reg. 4409064Status 706Registered
- Filing date
- Status date
- Registration date
- Oct 1, 2013
- Examiner
- FLETCHER, TRACY L
- Law office
- GENERIC WEB UPDATE
What this means
This trademark is registered with the USPTO. Monitoring new filings can help you catch lookalike marks early.
Need help with BOIRON?
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.
Owner
F-69510 MESSIMY, FR
F-69110 SAINTE FOY LES LYON, FR
F-69110 SAINTE FOY LES LYON, FR
Attorney of record
The USPTO lists this attorney as the applicant's representative for correspondence on this application.
Janet G Ricciuti
Janet G Ricciuti JANET GILBERT RICCIUTI, PC2003 KALORAMA ROAD NWWASHINGTON, DC 20009UNITED STATESGoods and services
| Class | Description | Status | First use |
|---|---|---|---|
| 003 | [ Toilet soap; Body deodorants; Essential oils; Cosmetics, namely, face creams, body creams, cleansing milk for toilet purposes, beauty masks, lotions for cosmetic use, softening talcum powder for toiletry use, bath gels, shower gels, sun tanning oils, creams and milks, and lipstick; Hair lotions, namely, shampoos; Dentifrices in the form of gel, paste and chewing gum ] | SECTION 71 - CANCELLED | — |
| 005 | Pharmaceutical and veterinary preparations, namely, homeopathic and phytotherapeutic preparations for the treatment of allergies, hay fever, motion sickness, [ heart failure, ] dermatologic use, namely, the treatment of dermatitis, [ skin pigmentation diseases, treatment of cold sores, ] treatment and prevention of dry skin, [ eczema, psoriasis, ] acne, for [the treatment of atopic skin, ] the treatment of sunburn, irritated skin, cracking, cracks, insect bites, minor wounds, rashes, warts, for the treatment of gynecological disorders, the treatment of hot flashes and functional problems associated with menopause, [ for the treatment of blood diseases and for the treatment of hepatic diseases, ] disorders of the digestive system, intestinal diseases, gastroenterological diseases, disease related to the imbalance of the intestinal flora, in the treatment of hemorrhoid attacks, diarrhea, [ for the treatment ] of urological infections, urinary functional disorders, for the treatment of diseases and symptoms within the central nervous system, namely, anxiety, spasms, sleep disorders, nervousness, irritability, nerves, apprehensiveness, emotional palpitations, [ epileptic origin, for use in oncology, ] for the treatment of eye diseases, treatment of eye strain, eye irritation, for the treatment of ear, nose and throat diseases, for the treatment of flu-like illness, the loss of voice, sore throat, hoarseness, laryngitis, rhinitis, colds, coughs, namely, for pediatric use, namely, for the treatment of symptoms related to teething in infants, namely, gum pain, restlessness and irritability, for the treatment of symptoms associated with abdominal colic baby, namely, abdominal pain, cramping, spasms and intestinal gas, for the treatment of flu symptoms in children, for the treatment of irritability and light sleep of the child, for treatment of symptoms due to seasonal and environmental allergies of the child, namely, sneezing, runny nose, watery eyes, itching and irritation of the throat, for the treatment of disorders and conditions involving the joints, muscles, tendons and ligaments, for the treatment of joint pain, muscle, muscle fatigue, cramps, fatigue states, [ for the treatment of toothache, ] for the treatment of infections of the mouth, for trauma use, for the treatment of bruises, bumps, aches, pain, fever, headaches [, vitamin-based nutritional supplements and mineral supplements; Nutritional supplements featuring essential fatty acids and amino acids, trace elements; Sanitary preparations for medical use; Dietetic substances, namely, nutritional supplements featuring vitamins, minerals and trace elements; All-purpose disinfectants; Dietary supplemental drinks in the nature of vitamin and mineral beverages ] | ACTIVE | — |
| 016 | [ Printed matter, namely, newspapers; Printed matter, namely, books, magazines and brochures featuring reviews all in the field of health; Stationery; Printed instructional and teaching materials not including apparatus in the field of health ] | SECTION 71 - CANCELLED | — |
Related trademarks
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
Prosecution history
| Date | Code | Event | What it means |
|---|---|---|---|
| Dec 21, 2024 | INNP | PARTIAL INVALIDATION PROCESSED BY THE IB | — |
| Nov 15, 2024 | INPS | PARTIAL INVALIDATION OF REG EXT PROTECTION SENT TO IB | — |
| Nov 15, 2024 | INPC | INVALIDATION PROCESSED | — |
| Oct 24, 2024 | INPR | PARTIAL INVALIDATION OF REG EXT PROTECTION CREATED | — |
| Feb 23, 2024 | NA71 | NOTICE OF ACCEPTANCE OF SEC. 71 - E-MAILED | — |
| Feb 23, 2024 | 71AG | REGISTERED-SEC.71 ACCEPTED | — |
| Feb 12, 2024 | APRE | CASE ASSIGNED TO POST REGISTRATION PARALEGAL | — |
| Oct 14, 2023 | NREP | NEW REPRESENTATIVE AT IB RECEIVED | — |
| Jun 7, 2023 | ES71 | TEAS SECTION 71 RECEIVED | — |
| Oct 1, 2022 | REM4 | COURTESY REMINDER - SEC. 71 (10-YR) E-MAILED | — |
| Aug 19, 2022 | RNWL | INTERNATIONAL REGISTRATION RENEWED | — |
| Nov 15, 2019 | NA75 | NOTICE OF ACCEPTANCE OF SEC. 71 & 15 - E-MAILED | — |
| Nov 15, 2019 | C75A | REGISTERED - SEC. 71 ACCEPTED & SEC. 15 ACK. | — |
| Nov 14, 2019 | NREP | NEW REPRESENTATIVE AT IB RECEIVED | — |
| Oct 31, 2019 | EROP | TEAS RESPONSE TO OFFICE ACTION-POST REG RECEIVED | — |
| Oct 2, 2019 | PR75 | POST REGISTRATION ACTION MAILED - SEC. 71 & 15 | — |
| Sep 27, 2019 | APRE | CASE ASSIGNED TO POST REGISTRATION PARALEGAL | — |
| Sep 23, 2019 | ES75 | TEAS SECTION 71 & 15 RECEIVED | — |
| Oct 1, 2018 | REM3 | COURTESY REMINDER - SEC. 71 (6-YR) E-MAILED | — |
| Feb 27, 2014 | CORN | CORRECTION FROM THE IB EXAMINED, NO ACTION IS NEEDED | — |
| Feb 21, 2014 | CRCV | CORRECTION TRANSACTION RECEIVED FROM IB | — |
| Feb 18, 2014 | FINO | FINAL DECISION TRANSACTION PROCESSED BY IB | — |
| Jan 8, 2014 | FICS | FINAL DISPOSITION NOTICE SENT TO IB | — |
| Jan 8, 2014 | FIMP | FINAL DISPOSITION PROCESSED | — |
| Jan 4, 2014 | ADCH | CHANGE OF NAME/ADDRESS REC'D FROM IB | — |
| Jan 1, 2014 | FICR | FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB | — |
| Oct 1, 2013 | R.PR | REGISTERED-PRINCIPAL REGISTER | Your trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive. |
| Jul 21, 2013 | GPNX | NOTIFICATION PROCESSED BY IB | — |
| Jul 16, 2013 | NPUB | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | — |
| Jul 16, 2013 | PUBO | PUBLISHED FOR OPPOSITION | Your mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance. |
| Jun 26, 2013 | OPNS | NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB | — |
| Jun 26, 2013 | OP2R | NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB | — |
| Jun 26, 2013 | NONP | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | — |
| Jun 12, 2013 | PREV | LAW OFFICE PUBLICATION REVIEW COMPLETED | — |
| Jun 8, 2013 | ALIE | ASSIGNED TO LIE | — |
| Jun 7, 2013 | CNSA | APPROVED FOR PUB - PRINCIPAL REGISTER | — |
| Jun 6, 2013 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| Jun 6, 2013 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Jun 6, 2013 | ALIE | ASSIGNED TO LIE | — |
| Jun 6, 2013 | TROA | TEAS RESPONSE TO OFFICE ACTION RECEIVED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Jan 8, 2013 | RFNT | REFUSAL PROCESSED BY IB | — |
| Dec 11, 2012 | RFCS | NON-FINAL ACTION MAILED - REFUSAL SENT TO IB | — |
| Dec 11, 2012 | RFRR | REFUSAL PROCESSED BY MPU | — |
| Dec 10, 2012 | RFCR | NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW | — |
| Dec 9, 2012 | CNRT | NON-FINAL ACTION WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Nov 30, 2012 | DOCK | ASSIGNED TO EXAMINER | — |
| Oct 30, 2012 | MAFR | APPLICATION FILING RECEIPT MAILED | — |
| Oct 26, 2012 | NWOS | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | — |
| Oct 23, 2012 | REPR | SN ASSIGNED FOR SECT 66A APPL FROM IB | — |